Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1D | P48730 | 11/20 | 0.51 |
| ▸ | ACP1 | P24666 | 1/20 | 0.51 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.50 |
| ▸ | RIPK1 | Q13546 | 3/20 | 0.47 |
| ▸ | RIPK3 | Q9Y572 | 3/20 | 0.47 |
| ▸ | KDR | P35968 | 2/20 | 0.46 |
| ▸ | TEK | Q02763 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21569134 | 0.87 | KDR (0.56) | CSNK1DACP1DYRK1AKDRTEK | |
| SCHEMBL21569113 | 0.84 | CSNK1D (0.54) | CSNK1DACP1DYRK1A | |
| SCHEMBL21568731 | 0.76 | CSNK1D (0.56) | CSNK1DACP1DYRK1AKDRTEK | |
| SCHEMBL21568107 | 0.75 | DYRK1A (0.58) | CSNK1DACP1DYRK1AKDRTEK | |
| SCHEMBL21568247 | 0.74 | DYRK1A (0.55) | CSNK1DACP1DYRK1AKDRTEK | |
| SCHEMBL21568248 | 0.74 | CSNK1D (0.70) | CSNK1DACP1DYRK1AKDRTEK | |
| SCHEMBL21568277 | 0.74 | DYRK1A (0.44) | CSNK1DDYRK1ARIPK1RIPK3KDR | |
| SCHEMBL21568065 | 0.73 | DYRK1A (0.57) | DYRK1ARIPK1RIPK3 | |
| SCHEMBL23256658 | 0.73 | DYRK1A (0.56) | CSNK1DACP1DYRK1AKDRTEK | |
| SCHEMBL21568278 | 0.73 | DYRK1A (0.56) | CSNK1DACP1DYRK1AKDRTEK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019217509-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | HB THERAPEUTICS INC. (US) | 2019-11-14 | — | — | WO | disclosed |